Eli Casdin - Aug 3, 2021 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director, 10%+ Owner
Signature
/s/ Eli Casdin
Stock symbol
TNYA
Transactions as of
Aug 3, 2021
Transactions value $
$12,750,000
Form type
4
Date filed
8/4/2021, 06:32 PM
Previous filing
Jul 29, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Conversion of derivative security $0 +2.37M $0.00 2.37M Aug 3, 2021 See Footnotes F1, F2
transaction TNYA Common Stock Purchase $12.8M +850K +35.79% $15.00 3.22M Aug 3, 2021 See Footnotes F1, F2
transaction TNYA Common Stock Conversion of derivative security $0 +362K $0.00 362K Aug 3, 2021 See Footnotes F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNYA Series B Preferred Stock Conversion of derivative security -2.01M -100% 0 Aug 3, 2021 Common Stock 2.01M $0.00 See Footnotes F1, F2, F4
transaction TNYA Series C Preferred Stock Conversion of derivative security -362K -100% 0 Aug 3, 2021 Common Stock 362K $0.00 See Footnotes F1, F2, F4
transaction TNYA Series C Preferred Stock Conversion of derivative security -362K -100% 0 Aug 3, 2021 Common Stock 362K $0.00 See Footnotes F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
F2 Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
F3 These shares are held directly by Casdin Private Growth Equity Fund, L.P. (CPGEF).
F4 Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date.